公开(公告)号：US09862934B2

公开(公告)日：2018-01-09

申请号：US14670459

申请日：2015-03-27

Applicant: GENETHON

Inventor： Otto-Wilhelm Merten ,  Martin Marek ,  Monique Van Oers

IPC: C12N15/866 ,  C12N15/86 ,  C12N7/00

CPC classification number: C12N7/00 ,  C12N15/86 ,  C12N2710/14143 ,  C12N2710/14152 ,  C12N2750/14143 ,  C12N2800/50

Abstract: The present invention relates to methods for the production of biopharmaceuticals implementing a baculovirus-based system. These methods advantageously allow the production of biopharmaceuticals with a reduced number of or without contaminating baculoviral virions.

公开(公告)号：US11236307B2

公开(公告)日：2022-02-01

申请号：US16551787

申请日：2019-08-27

Applicant: GENETHON

Inventor： Otto-Wilhelm Merten ,  Martin Marek ,  Monique Van Oers

IPC: C12N7/00 ,  C12N15/86

Abstract: The present invention relates to methods for the production of biopharmaceuticals implementing a baculovirus-based system. These methods advantageously allow the production of biopharmaceuticals with a reduced number of or without contaminating baculoviral virions.

公开(公告)号：US10428315B2

公开(公告)日：2019-10-01

申请号：US15841359

申请日：2017-12-14

Applicant: GENETHON

Inventor： Otto-Wilhelm Merten ,  Martin Marek ,  Monique Van Oers

IPC: C12N7/00 ,  C12N15/86 ,  C12N15/88

Abstract: The present invention relates to methods for the production of biopharmaceuticals implementing a baculovirus-based system. These methods advantageously allow the production of biopharmaceuticals with a reduced number of or without contaminating baculoviral virions.